Abstract
Vaccination has been shown to be the most successful measure in preventing millions of mortalities and morbidities related to infectious diseases. Higher rates of vaccination lead to a greater number of protected individuals in the community. While vaccine safety is a primary concern, misinformation accessed through various communication channels can lead to misconceptions about vaccination that are often hard to address. When the public collects information, they usually do not check for accuracy. To overcome the problem, the most effective way is to disseminate information through teaching facts about vaccine benefits and harms to the public and the authorities in advance. To encourage the public to participate and support vaccination programs, basic scientists and public health officials must be trained and updated about vaccines and vaccination benefits and harms to be able to inform the public.
Keywords: Communication, vaccines, vaccine preventable diseases, vaccine safety, vaccine teaching, vaccinology.
Current Drug Safety
Title:The Need to Teach Vaccine Safety to Basic Scientists and Public Health Officials
Volume: 10 Issue: 1
Author(s): Ali Khamesipour
Affiliation:
Keywords: Communication, vaccines, vaccine preventable diseases, vaccine safety, vaccine teaching, vaccinology.
Abstract: Vaccination has been shown to be the most successful measure in preventing millions of mortalities and morbidities related to infectious diseases. Higher rates of vaccination lead to a greater number of protected individuals in the community. While vaccine safety is a primary concern, misinformation accessed through various communication channels can lead to misconceptions about vaccination that are often hard to address. When the public collects information, they usually do not check for accuracy. To overcome the problem, the most effective way is to disseminate information through teaching facts about vaccine benefits and harms to the public and the authorities in advance. To encourage the public to participate and support vaccination programs, basic scientists and public health officials must be trained and updated about vaccines and vaccination benefits and harms to be able to inform the public.
Export Options
About this article
Cite this article as:
Khamesipour Ali, The Need to Teach Vaccine Safety to Basic Scientists and Public Health Officials, Current Drug Safety 2015; 10 (1) . https://dx.doi.org/10.2174/157488631001150407111101
DOI https://dx.doi.org/10.2174/157488631001150407111101 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Chemokines in the Pathogenesis and as Therapeutical Markers and Targets of HCV Chronic Infection and HCV Extrahepatic Manifestations
Current Drug Targets Anti-Inflammatory and Antioxidant Properties of Piper Species: A Perspective from Screening to Molecular Mechanisms
Current Topics in Medicinal Chemistry Recent Patents on Proteases and Kinases as Anti-Infective Agents: A Review
Recent Patents on Anti-Infective Drug Discovery Nanoparticles vs Cancer: A Multifuncional Tool
Current Topics in Medicinal Chemistry COVID-19: Are Experimental Drugs a Cure or Cause?
Current Drug Safety Recent Advances in the Development of Adenovirus- and Poxvirus- Vectored Tuberculosis Vaccines
Current Gene Therapy BMI1 Regulation of Self-Renewal and Multipotency in Human Mesenchymal Stem Cells
Current Stem Cell Research & Therapy Recent Advances in the Synthesis and Development of Nitroaromatics as Anti-Infective Drugs
Current Pharmaceutical Design Deciphering Role of Cytokines for Therapeutic Strategies Against Rheumatoid Arthritis
Current Drug Targets Formulation of Rifampicin Loaded PEGylated 5.0G EDA-PAMAM Dendrimers as Effective Long-Duration Release Drug Carriers
Current Drug Therapy Design, Synthesis and Biological Evaluation of Novel Tetrahydroquinoline Based Propanehydrazides as Antitubercular Agents
Letters in Drug Design & Discovery Update on Clinical, Pathophysiological and Therapeutic Aspects in ANCAAssociated Vasculitides
Current Drug Discovery Technologies Review of QSAR for DNA Polymerase Inhibitors and New Models for Heterogeneous Series of Compounds
Current Computer-Aided Drug Design New Perspectives in Drug Delivery Systems for the Treatment of Tuberculosis
Current Medicinal Chemistry Molecular Targets of Rheumatoid Arthritis
Inflammation & Allergy - Drug Targets (Discontinued) Pyrazoles and Fused Pyrimidines: Synthesis, Structure Elucidation, Antitubercular Activity and Molecular Docking Study
Medicinal Chemistry Synthesis, p38 Kinase Inhibitory and Anti-inflammatory Activity of New Substituted Benzimidazole Derivatives
Medicinal Chemistry Advances in Lipid-Based Subunit Vaccine Formulations
Current Immunology Reviews (Discontinued) Recent Advances in Thymidine Kinase 2 (TK2) Inhibitors and New Perspectives for Potential Applications
Current Pharmaceutical Design Drug Carriers in Pharmaceutical Design: Promises and Progress
Current Pharmaceutical Design